{"AXP": {"Ticker": "AXP", "Company": "American Express", "Sector": "Financials", "Updated": "2022-06-06", "Rating": [{"Date": "2022-06-06", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-05-12", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": "$146"}, {"Date": "2022-04-11", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$200"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["JP Morgan", "Wolfe Research", "Edward Jones"], "Price_Target": 114.33}, "AMT": {"Ticker": "AMT", "Company": "American Tower", "Sector": "Real Estate", "Updated": "2022-06-06", "Rating": [{"Date": "2022-06-06", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$315"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BofA Securities"], "Price_Target": 315.0}, "EIX": {"Ticker": "EIX", "Company": "Edison International", "Sector": "Utilities", "Updated": "2022-06-06", "Rating": [{"Date": "2022-06-06", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$75 to $73"}, {"Date": "2022-05-10", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$82 to $72"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["UBS", "Mizuho"], "Price_Target": 72.5}, "MRK": {"Ticker": "MRK", "Company": "Merck & Co.", "Sector": "Health Care", "Updated": "2022-06-06", "Rating": [{"Date": "2022-06-06", "Rating": "Resumed", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$102"}, {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$80"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Morgan Stanley", "SVB Leerink"], "Price_Target": 91.0}, "MNST": {"Ticker": "MNST", "Company": "Monster Beverage", "Sector": "Consumer Staples", "Updated": "2022-06-06", "Rating": [{"Date": "2022-06-06", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$111 to $117"}, {"Date": "2022-05-18", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$97 to $110"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Bernstein", "Morgan Stanley"], "Price_Target": 113.5}, "REGN": {"Ticker": "REGN", "Company": "Regeneron Pharmaceuticals", "Sector": "Health Care", "Updated": "2022-06-06", "Rating": [{"Date": "2022-06-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$536"}, {"Date": "2022-05-23", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$738"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "SVB Leerink"], "Price_Target": 637.0}, "RMD": {"Ticker": "RMD", "Company": "ResMed", "Sector": "Health Care", "Updated": "2022-06-06", "Rating": [{"Date": "2022-06-06", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$233 to $244"}, {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$280"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["RBC Capital Mkts", "Wolfe Research"], "Price_Target": 262.0}}